Donepezil for Treating Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)
J. Clin. Oncol 2024 May 06;[EPub Ahead of Print], SR Rapp, EV Dressler, WM Brown, JL Wade, N Le-Lindqwister, D King, KM Rowland, KE Weaver, HD Klepin, EG Shaw, GJ LesserFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.